CONTRI, CHIARA
CONTRI, CHIARA
Dipartimento di Medicina Traslazionale e per la Romagna
Adenosine and inflammation: Here, there and everywhere
2021 Pasquini, S.; Contri, C.; Borea, P. A.; Vincenzi, F.; Varani, K.
Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets
2022 Pasquini, S.; Contri, C.; Merighi, S.; Gessi, S.; Borea, P. A.; Varani, K.; Vincenzi, F.
Binding and unbinding of potent melatonin receptor ligands: Mechanistic simulations and experimental evidence
file con accesso da definire2024 Bedini, Annalida; Elisi, Gian Marco; Fanini, Fabiola; Retini, Michele; Scalvini, Laura; Pasquini, Silvia; Contri, Chiara; Varani, Katia; Spadoni, Gilberto; Mor, Marco; Vincenzi, Fabrizio; Rivara, Silvia
Caffeine for Prevention of Alzheimer's Disease: Is the A2A Adenosine Receptor Its Target?
2023 Merighi, Stefania; Travagli, Alessia; Nigro, Manuela; Pasquini, Silvia; Cappello, Martina; Contri, Chiara; Varani, Katia; Vincenzi, Fabrizio; Borea, Pier Andrea; Gessi, Stefania
Cytotoxic and Antiproliferative Effects of [64Cu]CuCl2 in Tumor Cells for Radiometabolic Therapy: a Preliminary Study
file con accesso da definire2024 Porto, Francesca; Speltri, Giorgia; Pasquini, Silvia; Contri, Chiara; Cappello, Martina; Martini, Petra; Boschi, Alessandra; Uccelli, Licia; Varani, Katia; DI DOMENICO, Giovanni; Vincenzi, Fabrizio
Cytotoxic and Antiproliferative Effects of [64Cu]CuCl2 in Tumor Cells for Radiometabolic Therapy: a Preliminary Study.
file con accesso da definire2024 Porto, Francesca; Speltri, Giorgia; Contri, Chiara; Cappello, Martina; Martini, Petra; Boschi, Alessandra; Uccelli, Licia; Varani, Katia; DI DOMENICO, Giovanni; Vincenzi, Fabrizio
Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions
2023 Papa, Alessandro; Pasquini, Silvia; Galvani, Francesca; Cammarota, Mariarosaria; Contri, Chiara; Carullo, Gabriele; Gemma, Sandra; Ramunno, Anna; Lamponi, Stefania; Gorelli, Beatrice; Saponara, Simona; Varani, Katia; Mor, Marco; Campiani, Giuseppe; Boscia, Francesca; Vincenzi, Fabrizio; Lodola, Alessio; Butini, Stefania
PHARMACOLOGICAL CHARACTERIZATION OF NEW MODULATORS OF THE ENDOCANNABINOID SYSTEM: FROM SINGLE TARGET TO MULTI-TARGET COMPOUNDS
2024 Contri, Chiara
Pharmacology of Adenosine Receptors: Recent Advancements
file con accesso da definire2023 Vincenzi, Fabrizio; Pasquini, Silvia; Contri, Chiara; Cappello, Martina; Nigro, Manuela; Travagli, Alessia; Merighi, Stefania; Gessi, Stefania; Borea, Pier Andrea; Varani, Katia
Pioneering first-in-class FAAH-HDAC inhibitors as potential multitarget neuroprotective agents
2023 Papa, Alessandro; Cursaro, Ilaria; Pozzetti, Luca; Contri, Chiara; Cappello, Martina; Pasquini, Silvia; Carullo, Gabriele; Ramunno, Anna; Gemma, Sandra; Varani, Katia; Butini, Stefania; Campiani, Giuseppe; Vincenzi, Fabrizio
Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition
2022 Papa, A.; Pasquini, S.; Contri, C.; Gemma, S.; Campiani, G.; Butini, S.; Varani, K.; Vincenzi, F.
Synthesis of Unsymmetrical Squaramides as Allosteric GSK-3β Inhibitors Promoting β-Catenin-Mediated Transcription of TCF/LEF in Retinal Pigment Epithelial Cells
2022 Carullo, G.; Bottoni, L.; Pasquini, S.; Papa, A.; Contri, C.; Brogi, S.; Calderone, V.; Orlandini, M.; Gemma, S.; Varani, K.; Butini, S.; Galvagni, F.; Vincenzi, F.; Campiani, G.
Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applications
2022 Pasquini, Silvia; Contri, Chiara; Cappello, Martina; Borea, Pier Andrea; Varani, Katia; Vincenzi, Fabrizio
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Adenosine and inflammation: Here, there and everywhere | 2021 | Pasquini, S.; Contri, C.; Borea, P. A.; Vincenzi, F.; Varani, K. | |
Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets | 2022 | Pasquini, S.; Contri, C.; Merighi, S.; Gessi, S.; Borea, P. A.; Varani, K.; Vincenzi, F. | |
Binding and unbinding of potent melatonin receptor ligands: Mechanistic simulations and experimental evidence | 2024 | Bedini, Annalida; Elisi, Gian Marco; Fanini, Fabiola; Retini, Michele; Scalvini, Laura; Pasquini,... Silvia; Contri, Chiara; Varani, Katia; Spadoni, Gilberto; Mor, Marco; Vincenzi, Fabrizio; Rivara, Silvia | file con accesso da definire |
Caffeine for Prevention of Alzheimer's Disease: Is the A2A Adenosine Receptor Its Target? | 2023 | Merighi, Stefania; Travagli, Alessia; Nigro, Manuela; Pasquini, Silvia; Cappello, Martina; Contri..., Chiara; Varani, Katia; Vincenzi, Fabrizio; Borea, Pier Andrea; Gessi, Stefania | |
Cytotoxic and Antiproliferative Effects of [64Cu]CuCl2 in Tumor Cells for Radiometabolic Therapy: a Preliminary Study | 2024 | Porto, Francesca; Speltri, Giorgia; Pasquini, Silvia; Contri, Chiara; Cappello, Martina; Martini,... Petra; Boschi, Alessandra; Uccelli, Licia; Varani, Katia; DI DOMENICO, Giovanni; Vincenzi, Fabrizio | file con accesso da definire |
Cytotoxic and Antiproliferative Effects of [64Cu]CuCl2 in Tumor Cells for Radiometabolic Therapy: a Preliminary Study. | 2024 | Porto, Francesca; Speltri, Giorgia; Contri, Chiara; Cappello, Martina; Martini, Petra; Boschi, Al...essandra; Uccelli, Licia; Varani, Katia; DI DOMENICO, Giovanni; Vincenzi, Fabrizio | file con accesso da definire |
Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions | 2023 | Papa, Alessandro; Pasquini, Silvia; Galvani, Francesca; Cammarota, Mariarosaria; Contri, Chiara; ...Carullo, Gabriele; Gemma, Sandra; Ramunno, Anna; Lamponi, Stefania; Gorelli, Beatrice; Saponara, Simona; Varani, Katia; Mor, Marco; Campiani, Giuseppe; Boscia, Francesca; Vincenzi, Fabrizio; Lodola, Alessio; Butini, Stefania | |
PHARMACOLOGICAL CHARACTERIZATION OF NEW MODULATORS OF THE ENDOCANNABINOID SYSTEM: FROM SINGLE TARGET TO MULTI-TARGET COMPOUNDS | 2024 | Contri, Chiara | |
Pharmacology of Adenosine Receptors: Recent Advancements | 2023 | Vincenzi, Fabrizio; Pasquini, Silvia; Contri, Chiara; Cappello, Martina; Nigro, Manuela; Travagli..., Alessia; Merighi, Stefania; Gessi, Stefania; Borea, Pier Andrea; Varani, Katia | file con accesso da definire |
Pioneering first-in-class FAAH-HDAC inhibitors as potential multitarget neuroprotective agents | 2023 | Papa, Alessandro; Cursaro, Ilaria; Pozzetti, Luca; Contri, Chiara; Cappello, Martina; Pasquini, S...ilvia; Carullo, Gabriele; Ramunno, Anna; Gemma, Sandra; Varani, Katia; Butini, Stefania; Campiani, Giuseppe; Vincenzi, Fabrizio | |
Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition | 2022 | Papa, A.; Pasquini, S.; Contri, C.; Gemma, S.; Campiani, G.; Butini, S.; Varani, K.; Vincenzi, F. | |
Synthesis of Unsymmetrical Squaramides as Allosteric GSK-3β Inhibitors Promoting β-Catenin-Mediated Transcription of TCF/LEF in Retinal Pigment Epithelial Cells | 2022 | Carullo, G.; Bottoni, L.; Pasquini, S.; Papa, A.; Contri, C.; Brogi, S.; Calderone, V.; Orlandini..., M.; Gemma, S.; Varani, K.; Butini, S.; Galvagni, F.; Vincenzi, F.; Campiani, G. | |
Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applications | 2022 | Pasquini, Silvia; Contri, Chiara; Cappello, Martina; Borea, Pier Andrea; Varani, Katia; Vincenzi,... Fabrizio |